IOL Chemicals and Pharmaceuticals

₹184.29As of Sun 8 Nov 2026, 12:00 UTC

NSE:IOLCPHealthcare

Country India

PE (Fwd) 36.56

TSR 10Y CAGR 22.30%

Div yield 0.54%

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 0.55

PE TTM 39.30

TSR TTM 101.87%

Mkt cap ₹59.35B

ROIC —

SE Grade™

Value

Quality

Moat

—

1Y Price

Reference

₹206

11.83%

(78.76%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

23.19

Revenue₹B

—

21.84

22.17

21.33

20.79

23.19

24.15

1.51%

11.54

Revenue growth%

—

1.52

(3.80)

(2.51)

11.54

4.15

(0.50)

—

34.59

Gross margin%

—

27.60

29.61

33.49

31.84

34.59

34.66

31.84

8.17

Operating margin%

—

9.90

8.12

7.86

6.28

8.17

8.12

5.94

Net margin%

—

7.68

6.28

6.30

4.86

5.94

5.89

6.28

39.30

P/E ratio (avg)x

—

19.35

16.14

18.90

24.30

20.00

38.02

19.35

28.54

EV/EBITx

—

15.01

12.47

15.15

18.82

14.53

27.59

15.01

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

4.69

EPS₹

—

5.71

4.74

4.58

3.44

4.69

4.85

(4.81%)

—

36.18

EPS growth%

—

(17.02)

(3.39)

(24.82)

36.18

3.38

(10.20)

—

Bookvalue per sh₹

—

FCF per share₹

—

1.00

Dividend per sh₹

—

0.80

1.00

0.80

1.00

1.05

5.74%

—

0.54

Div yield (avg)%

—

0.72

1.05

1.16

0.96

1.07

0.57

1.05

21.33

Payout ratio%

—

14.01

16.88

21.83

23.26

21.33

21.58

21.33

293.5

Shares (diluted)M

—

293.5

◌293.5

—

Buyback yield%

—

◌—

—

D/E ratiox

—

54.09

Enterprise value₹B

—

32.44

22.46

25.40

24.56

27.53

54.09

(4.02%)

—

LT debt₹M

—

Peers (US$575.6M)

Cap (US$)

Orchid Pharma Limited

552.2M

149.0x

Morepen Laboratories…

536.8M

26.74x

Gujarat Themis Biosyn…

532.4M

86.19x

Nanjing Hicin Pharmace…

572.6M

53.31x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

18.97

16.85

Own earn%

—

Sh yield%

0.54

1.06

Owners

Insiders/Inst%

2.04

1.85

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

5/5

Revenue growth years

2/4

EPS growth years

1/4

Dividend streakyrs

Op margin range%

6–10

$1 testx

—

Incr. ROIC%

—

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. It operates through two segments: Pharmaceuticals and Specialty Chemicals.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹23.19B

1.51%

1.00×

Cost of revenue

₹15.17B

(1.03%)

0.90×

Operating expenses

₹6.128B

12.20%

1.49×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m